Pharma Claims “Devastating” Consequences from Just-Released IRA Drug Pricing

From a warning that the new pricing scheme doesn’t mean patients are protected from increased costs to another that the Inflation Reduction Act (IRA) pricing scheme will limit patients’ access to medicines now and in the future, big pharma has expressed its displeasure with the public unveiling of prices.
Source: Drug Industry Daily